Skip to main content
Journal cover image

Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.

Publication ,  Journal Article
Rose, S; Niyazov, DM; Rossignol, DA; Goldenthal, M; Kahler, SG; Frye, RE
Published in: Mol Diagn Ther
October 2018

Autism spectrum disorder (ASD) affects ~ 2% of children in the United States. The etiology of ASD likely involves environmental factors triggering physiological abnormalities in genetically sensitive individuals. One of these major physiological abnormalities is mitochondrial dysfunction, which may affect a significant subset of children with ASD. Here we systematically review the literature on human studies of mitochondrial dysfunction related to ASD. Clinical aspects of mitochondrial dysfunction in ASD include unusual neurodevelopmental regression, especially if triggered by an inflammatory event, gastrointestinal symptoms, seizures, motor delays, fatigue and lethargy. Traditional biomarkers of mitochondrial disease are widely reported to be abnormal in ASD, but appear non-specific. Newer biomarkers include buccal cell enzymology, biomarkers of fatty acid metabolism, non-mitochondrial enzyme function, apoptosis markers and mitochondrial antibodies. Many genetic abnormalities are associated with mitochondrial dysfunction in ASD, including chromosomal abnormalities, mitochondrial DNA mutations and large-scale deletions, and mutations in both mitochondrial and non-mitochondrial nuclear genes. Mitochondrial dysfunction has been described in immune and buccal cells, fibroblasts, muscle and gastrointestinal tissue and the brains of individuals with ASD. Several environmental factors, including toxicants, microbiome metabolites and an oxidized microenvironment are shown to modulate mitochondrial function in ASD tissues. Investigations of treatments for mitochondrial dysfunction in ASD are promising but preliminary. The etiology of mitochondrial dysfunction and how to define it in ASD is currently unclear. However, preliminary evidence suggests that the mitochondria may be a fruitful target for treatment and prevention of ASD. Further research is needed to better understand the role of mitochondrial dysfunction in the pathophysiology of ASD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mol Diagn Ther

DOI

EISSN

1179-2000

Publication Date

October 2018

Volume

22

Issue

5

Start / End Page

571 / 593

Location

New Zealand

Related Subject Headings

  • Stress, Physiological
  • Pharmacology & Pharmacy
  • Oncology & Carcinogenesis
  • Mitochondrial Diseases
  • Mitochondria
  • Humans
  • Genetic Predisposition to Disease
  • Gastrointestinal Tract
  • Fatty Acids
  • Environment
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rose, S., Niyazov, D. M., Rossignol, D. A., Goldenthal, M., Kahler, S. G., & Frye, R. E. (2018). Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder. Mol Diagn Ther, 22(5), 571–593. https://doi.org/10.1007/s40291-018-0352-x
Rose, Shannon, Dmitriy M. Niyazov, Daniel A. Rossignol, Michael Goldenthal, Stephen G. Kahler, and Richard E. Frye. “Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.Mol Diagn Ther 22, no. 5 (October 2018): 571–93. https://doi.org/10.1007/s40291-018-0352-x.
Rose S, Niyazov DM, Rossignol DA, Goldenthal M, Kahler SG, Frye RE. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder. Mol Diagn Ther. 2018 Oct;22(5):571–93.
Rose, Shannon, et al. “Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.Mol Diagn Ther, vol. 22, no. 5, Oct. 2018, pp. 571–93. Pubmed, doi:10.1007/s40291-018-0352-x.
Rose S, Niyazov DM, Rossignol DA, Goldenthal M, Kahler SG, Frye RE. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder. Mol Diagn Ther. 2018 Oct;22(5):571–593.
Journal cover image

Published In

Mol Diagn Ther

DOI

EISSN

1179-2000

Publication Date

October 2018

Volume

22

Issue

5

Start / End Page

571 / 593

Location

New Zealand

Related Subject Headings

  • Stress, Physiological
  • Pharmacology & Pharmacy
  • Oncology & Carcinogenesis
  • Mitochondrial Diseases
  • Mitochondria
  • Humans
  • Genetic Predisposition to Disease
  • Gastrointestinal Tract
  • Fatty Acids
  • Environment